Show simple item record

dc.contributor.authorAng, Zen Yang
dc.contributor.authorBoddy, Michael
dc.contributor.authorLiu, Yandi
dc.contributor.authorSunderland, Bruce
dc.identifier.citationAng, Z. and Boddy, M. and Liu, Y. and Sunderland, B. 2016. Stability of apomorphine in solutions containing selected antioxidant agents. Drug Design, Development and Therapy. 10: pp. 3253-3265.

Apomorphine in solution undergoes rapid autoxidation, producing greenish colored solutions, making it difficult to formulate as a stable pharmaceutical solution. To identify the optimum antioxidant agent/combination for apomorphine solution, a high performance liquid chromatography assay was used to study the stability of 50 µg/mL apomorphine HCI in 0.1% L-ascorbic acid (AA), 0.1% sodium metabisulfite (SMB), 0.1% EDTA, and in selected combinations at 25°C, 32°C, and 37°C over a period of 14 days. The stability of apomorphine HCl (10 mg/mL) in 0.1% AA solution and in 0.1% EDTA solution at 25°C and 37°C was also evaluated. Apomorphine HCI solution (50 µg/mL) in 0.1% AA plus 0.1% SMB solution retained 99.7% (at 25°C) and 95.9% (at 37°C) of the initial concentration, as 0.1% AA plus SMB solution minimized the reactive oxygen content in solution which, in turn, reduced the oxidation rate of apomorphine HCl, and there was no green coloration perceptible. Conversely, apomorphine HCl solution (50 µg/mL) in 0.1% SMB solution was unstable as only 0.53% (at 25°C) and 0.06% (at 37°C) of the initial concentration was retained after 14 days. All 10 mg/mL apomorphine HCl samples were stable in both studies. The initial concentration of apomorphine HCl solution markedly affected its rate of oxidation and discoloration. The addition of 0.1% AA to a current formulation of apomorphine HCl injection (Apomine(®)), which contains SMB as an antioxidant, was recommended as providing the most stable solution.

dc.publisherDove Medical Press Ltd.
dc.titleStability of apomorphine in solutions containing selected antioxidant agents
dc.typeJournal Article
dcterms.source.titleDrug Design, Development and Therapy
curtin.departmentSchool of Pharmacy
curtin.accessStatusOpen access

Files in this item


This item appears in the following Collection(s)

Show simple item record
Except where otherwise noted, this item's license is described as